Adesão à terapia antirretroviral por pessoa vivendo com HIV/AIDS atendidos

Abstract

The study aims to identify the clinicai aspects and classify adherence to antiretroviral therapy for people living with HIV/AIDS who started treatment between January 2015 and December 2017 in an Infectious and Parasitic Diseases Unit of a university hospital. This research presents a quantitative, descriptive and cross-sectional approach. Data collection was carried out by analyzing secondary data collected through the Electronic Patient Record, Report System - SISCEL and SISGENO Reports and Results Printing Module of the Ministry of Health in the Department of IST, AIDS and Virai and System Hepatitis of Logistic Control of Medicines at the Clinicai Pharmacy and Outpatient Pharmaceutical Dispensing Unit. Results: The sample consisted of 142 patients of both sexes, ranging in age from 18 to 76 years. The percentage of continuity of clinicai and pharmacological follow-up was 77.4% and 85.2%, respectively, and that complete abandonment of treatment was higher among men (7.8%). It was possible to verify that the ARV schemes adopted are within the recommendations of the Ministry of Health, that 60.6% of the patients did not need to modify their ARVs and that 76.6% had undetectable virai load and LT-CD4 + values above 350 cells./mm3. Conclusion: Adherence to treatment is a constant challenge for patients and that family support and identification with health professionals are extremely important to overcome adversity, in addition to the social and individual perceptions that seropositivity represents.